valiolamine has been researched along with miglustat in 1 studies
| Studies (valiolamine) | Trials (valiolamine) | Recent Studies (post-2010) (valiolamine) | Studies (miglustat) | Trials (miglustat) | Recent Studies (post-2010) (miglustat) |
|---|---|---|---|---|---|
| 16 | 0 | 4 | 383 | 28 | 185 |
| Protein | Taxonomy | valiolamine (IC50) | miglustat (IC50) |
|---|---|---|---|
| Sucrase-isomaltase | Mus musculus (house mouse) | 1.05 | |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 5.55 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 5 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.1 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.5 | |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 2.156 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 5 | |
| Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
| Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 9 | |
| Non-lysosomal glucosylceramidase | Mus musculus (house mouse) | 0.14 | |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 3.7 | |
| Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.2057 | |
| Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aakula, B; Hill, ML; Karade, SS; Kiappes, JL; Manne, R; Mariuzza, RA; Treston, AM; Warfield, KL; Zitzmann, N | 1 |
1 other study(ies) available for valiolamine and miglustat
| Article | Year |
|---|---|
N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
Topics: alpha-Glucosidases; Animals; Antiviral Agents; Binding Sites; Chlorocebus aethiops; Crystallography, X-Ray; Dengue Virus; Endoplasmic Reticulum; Glycoside Hydrolase Inhibitors; Humans; Imino Sugars; Inositol; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Binding; SARS-CoV-2; Vero Cells | 2021 |